Medicaid managed care may enter a margin-recovery phase around 2027

Overview

This report summarizes Bernstein's Medicaid managed care Teach-in held on July 30, outlining the history, market structure, policy changes, state-level operating mechanisms, and margin cycle of US Medicaid. The report believes Medicaid will benefit over the long term from safety-net expansion and managed-care penetration, but will face enrollment contraction and federal cost-containment reforms in the near term. As rates gradually compensate for costs, industry margins are expected to stabilize and begin recovering around 2027.

Core views

Medicaid holds a central position in the US healthcare system: enrollment increased substantially during the pandemic and then declined rapidly following eligibility redeterminations. Managed care now covers most beneficiaries, but high-cost elderly and disabled populations still have relatively low penetration, creating a long-term growth opportunity. OBBBA reforms are expected to reduce enrollment and increase the uninsured population mainly through mechanisms such as work requirements and eligibility reviews. For insurers, the most important near-term variables are whether state rate adjustments can continue to catch up with medical costs, whether the risk pool stabilizes, and whether they can leverage scale to reduce administrative expense ratios in competition for state contracts.

Analysis framework

The report uses a framework combining US health insurance coverage and spending structures, historical Medicaid enrollment trends, policy provisions, state-level financing and rate-setting processes, and evaluates industry prospects through pre- and post-pandemic enrollment changes, managed-care penetration, OBBBA impact estimates, and state-level case studies.

Methodology notes

• Industry structure analysisHealth insurance coverage and spending segmentation

  Compares the coverage and spending structures of commercial insurance, Medicaid, Medicare, ACA Marketplace plans, and uninsured populations.

  Used to assess changes in the share of government-sponsored insurance in the US healthcare system and Medicaid's long-term strategic position.

• Policy scenario analysisOBBBA impact assessment

  Disaggregates the effects of reforms such as work requirements, provider taxes, state-directed payments, and eligibility redeterminations on spending, enrollment, and uninsured populations.

  Used to identify the medium-term effects of policy on Medicaid scale, state fiscal pressure, and the managed-care operating environment.

• Earnings-cycle analysisRate-cost trend analysis

  Tracks state rate adjustments, medical-cost trends, and changes in risk-pool composition following eligibility redeterminations.

  Used to determine when Medicaid managed care margins will shift from pressure to stabilization and recovery.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• CNC

  Medicaid managed care insurance operator

  Strengths

  The report assigns an Outperform rating and a $79 price target; the company could benefit if rates catch up with costs and margins recover.

  Weaknesses

  Highly sensitive to Medicaid policy, enrollment, and state-level rates.

  Comparison

  Benefits alongside other large managed-care operators from scale and administrative efficiency.

  Risks

  OBBBA reforms, eligibility redeterminations, above-expected medical costs, and competition for state contracts.

• CI

  Diversified health insurer

  Strengths

  The report assigns an Outperform rating and a $381 price target.

  Weaknesses

  Medicaid is only one part of its broader insurance business, so transmission of the industry theme is relatively dispersed.

  Comparison

  More diversified than pure-play Medicaid operators.

  Risks

  Policy, medical-cost, and insurance-business execution risks.

• CVS

  Integrated healthcare and insurance platform

  Strengths

  The report assigns an Outperform rating and a $106 price target.

  Weaknesses

  The impact of Medicaid improvement on overall performance is constrained by other business segments.

  Comparison

  Has broader exposure to healthcare services and pharmacy businesses than pure-play insurers.

  Risks

  Health insurance policy, cost trends, and multi-business integration execution risks.

• ELV

  Large government and commercial insurance operator

  Strengths

  The report assigns an Outperform rating and a $488 price target; scale and state-level operating capabilities support cost leverage and contract retention.

  Weaknesses

  The report notes its exit from Washington, D.C. and potential exit from additional selective markets, reflecting margin pressure in some markets.

  Comparison

  Has scale advantages in government insurance and is well positioned for the state trend toward provider consolidation.

  Risks

  Market exits, inadequate rates, policy cuts, and contract-renewal risks.

• HUM

  Health insurance operator

  Strengths

  The report assigns an Outperform rating and a $425 price target.

  Weaknesses

  Medicaid is not its sole core earnings driver.

  Comparison

  Less sensitive to this theme than companies with greater Medicaid specialization.

  Risks

  Government health insurance policy and medical-cost risks.

• Molina

  Medicaid managed care insurance operator

  Strengths

  The report assigns an Outperform rating and a $266 price target; it has high benefit sensitivity to long-term increases in managed-care penetration.

  Weaknesses

  Its high Medicaid exposure also makes it more directly exposed to enrollment declines and state-level policy changes.

  Comparison

  The impact of the Medicaid earnings cycle is more concentrated than for diversified insurers.

  Risks

  Enrollment contraction, rate lags, medical utilization, and state-contract risks.

• UNH

  Integrated health insurance and healthcare services platform

  Strengths

  The report assigns an Outperform rating and a $512 price target; business scale and diversification can cushion volatility from a single Medicaid cycle.

  Weaknesses

  The marginal impact of Medicaid recovery on group-wide performance may be lower than for operators focused on this business.

  Comparison

  Has a broader platform and scale advantage relative to peers.

  Risks

  Regulatory, medical-cost, and government-business policy changes.

• AGL

  Covered healthcare-services-related name

  Strengths

  The report assigns a Market-Perform rating and an $86 price target.

  Weaknesses

  The report does not identify it as a primary direct beneficiary of Medicaid margin recovery.

  Comparison

  Its rating is below that of most health insurers in the report that are rated Outperform.

  Risks

  Industry policy and company-specific operating execution risks.

• HCA

  Healthcare services provider

  Strengths

  The report assigns a Market-Perform rating and a $426 price target.

  Weaknesses

  Medicaid reimbursement and a rising uninsured population may affect the hospital payment mix.

  Comparison

  More directly exposed than insurance operators to changes in the patient payment mix.

  Risks

  A rising uninsured population, Medicaid payment pressure, and fluctuations in healthcare-service demand.

Key data

• Government safety-net enrollmentApproximately 33 million (1999) increased to more than 80 million (2024)The report defines the safety net as programs including Medicaid, CHIP, and subsidized public exchanges.
• Medicaid enrollment as a share of the populationApproximately 8% in 1987; peak of approximately 29% during the pandemic; currently close to 24%Reflects the effects of long-term expansion and post-pandemic eligibility redeterminations.
• Managed care penetrationApproximately 75% of Medicaid beneficiaries are enrolled in managed careHowever, approximately 46% of Medicaid spending remains under fee-for-service arrangements.
• Post-pandemic enrollment changeNearly 95 million in May 2023, falling to approximately 80 million by mid-2024A significant contraction occurred after states resumed eligibility verification.
• Pace of enrollment decline after 2025Approximately 1.0% to 1.5% per quarterThe report attributes this to advancing policies that reduce Medicaid funding.
• Medicaid program sizeApproximately $870 billion in 2024The federal government bears approximately 67%, while state governments bear approximately 33%.
• OBBBA ten-year spending cutsApproximately $886 billion (2025–2034)The table lists multiple reforms, including work requirements, provider taxes, and state-directed payments.
• OBBBA impact on enrollmentMedicaid enrollment is expected to decline by approximately 10 million over the coming decadeThe report believes the largest effect comes from declining enrollment; the table totals an impact of approximately 7.5 million people, with specific definitions varying by provision and timing.
• Work requirements80 hours per monthCan be met through work, vocational training, education, or community service; implementation begins in January 2027 and must be completed no later than January 2029.
• Margin outlookRecovery may begin around 2027Contingent on rates continuing to catch up with costs and further easing of risk-pool pressure caused by eligibility redeterminations.

Impact & implications

The industry faces near-term scale contraction and policy uncertainty, particularly unfavorable for operators with high Medicaid exposure or reliance on state-directed payments or enrollment growth. However, for managed-care organizations with scale, cost-management capabilities, strong state-contract execution, and rate-negotiation capabilities, risk-pool normalization and rate catch-up can drive margin recovery. Over the long term, migration of high-cost ABD populations into managed care, together with state efforts to consolidate providers to control costs, may further increase penetration and concentration among leading operators.

Risks

• Uncertainty remains regarding the scope and timing of implementation of OBBBA-related work requirements, eligibility redeterminations, provider-tax restrictions, and cuts to state-directed payments.
• Declining Medicaid enrollment may compress premium revenue and scale benefits.
• If rate adjustments continue to lag medical-cost trends, margin recovery will be delayed or impeded.
• If the medical complexity of members retained after eligibility redeterminations continues to increase, claim costs may rise.
• State fiscal pressure may affect contract terms, payment levels, benefit design, and the number of providers.
• State-level contract competition and industry consolidation may result in market exits, pricing pressure, or share volatility.
• Healthcare policy issues around the 2028 election cycle may introduce additional regulatory uncertainty.

What to watch

• Whether state Medicaid rate updates continue to cover medical-cost trends.
• Changes in medical utilization, disease severity, and medical loss ratios in the post-redetermination risk pool.
• Implementation timing, exemption arrangements, and legal challenges related to OBBBA work requirements and eligibility-redetermination rules.
• Monthly Medicaid and CHIP enrollment, especially the pace of decline after 2027.
• State-government responses to adjustments in provider taxes and state-directed payments.
• Progress in moving high-cost populations such as ABD into managed care.
• Administrative expense ratios, state-contract renewals, market exits, and new contract wins among large operators.
• The direction of discussions on public options, subsidies, and Medicaid policy during the 2028 election cycle.